Bright Path Laboratories (BPL) is positioned to immediately fill gaps in the drug supply chain in response to the COVID-19 pandemic and other medicine shortages.

Manufacturing

Pharmaceutical

Technology

Bright Path Labs

Bright Path Labs' headquarters in Kannapolis, NC, United States

Tony Quiñones

Jerry Irwin

Terry Novak

Heather Buchanan

Dennis Cope

Roger Quan

Rolando Rodriguez

John Lalonde

Xiping Su

Shiraz Kotte

The Advisory and Governance Team at Bright Path Labs plays a crucial role in shaping strategic decisions and ensuring compliance with industry regulations. Comprising experienced advisors and board members, the team provides expertise to navigate challenges in the drug supply chain, particularly in response to critical health crises like the COVID-19 pandemic. Their guidance helps to align innovation with governance best practices, ensuring the organization's mission is achieved effectively and responsibly.

Advisory and Governance Team

The Leadership Team at Bright Path Labs is responsible for guiding the strategic vision and operational execution of the company. Comprising key executives such as the CEO, Chief Commercial Officer, and Chief Innovation Officer, the team focuses on addressing urgent medicine shortages and optimizing the drug supply chain, particularly in response to the evolving challenges posed by the COVID-19 pandemic. Their collaborative leadership ensures innovation, efficiency, and responsiveness in delivering critical healthcare solutions.

Leadership Team

Bright Path Labs

Org chart

Board & advisors

Teams

Advisory and Governance Team

Leadership Team

Offices

Bright Path Labs

Org chart

Board & advisors

Teams

Advisory and Governance Team

Leadership Team

Offices

Related companies